| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |